Karin Johansson Wingstrand

Member of the Board of Directors

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
2
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity Feb 10, 2017 – Mar 13, 2024

Karin Johansson Wingstrand reported 17 transactions between Feb 10, 2017 and Mar 13, 2024. The buy and sell totals below count only code SACQ.

Open-market buys (SACQ)
1.29M SEK
12 purchases on file priced rows only
Open-market sales
None
0 sales on file
All reported transactions
17
every code, including awards and exercises
Pattern
No transaction in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

4 insiders bought Xbrane Biopharma AB shares worth 530,821 SEK between Aug 31, 2023 and Sep 19, 2023

Cluster buying

4 different insiders made 5 open-market purchases of this company’s shares within a short window. Each row below is one reported trade. At least one price in this event could not be cross-checked against other trades in the same security, so read the total with extra care.

4 insiders bought Xbrane Biopharma AB shares worth 530,821 SEK between Aug 31, 2023 and Sep 19, 2023
Date Insider Transaction Shares Price Value Filing
Aug 31, 2023 Anette Lindqvist SACQ Acquisition 1,503 34.92 SEK 52,485 SEK FI filing ↗
Sep 7, 2023 Siavash Bashiri SACQ Acquisition 1,417 32.14 SEK 45,547 SEK FI filing ↗
Sep 7, 2023 Karl Martin Erik Åmark SACQ Acquisition 8,000 32.85 SEK 262,800 SEK FI filing ↗
Sep 8, 2023 Siavash Bashiri SACQ Acquisition 621 32.99 SEK 20,489 SEK FI filing ↗
Sep 19, 2023 Karin Johansson Wingstrand SACQ Acquisition 5,000 29.90 SEK 149,500 SEK FI filing ↗

Total of the rows above: 530,821 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 17 most recent rows are grouped into 16 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Xbrane Biopharma AB SACQ Acquisition 25,480 shares 293.0K SEK at 11.50 SEK FI filing ↗
  2. Xbrane Biopharma AB SACQ Acquisition 5,000 shares 149.5K SEK at 29.90 SEK FI filing ↗
  3. Integrum AB SSUB Subscriptionnot a buy/sell decision 20,000 shares 311.0K SEK at 15.55 SEK FI filing ↗
  4. Xintela AB SACQ Acquisition 210,000 shares 52.5K SEK at 0.25 SEK FI filing ↗
  5. Integrum AB SACQ Acquisition 20,000 shares 177.6K SEK at 8.88 SEK FI filing ↗
  6. Xintela AB SEXI Exercise increasenot a buy/sell decision 22,500 shares 51.3K SEK at 2.28 SEK FI filing ↗
  7. Xintela AB SEXD Exercise decreasenot a buy/sell decisionreported at zero 22,500 shares 0 SEK at 0.00 SEK FI filing ↗
  8. Integrum AB SACQ Acquisition 20,000 shares 41.6K SEK at 2.08 SEK FI filing ↗
  9. Integrum AB SSUB Subscriptionnot a buy/sell decision 18,518 shares 100.0K SEK at 5.40 SEK FI filing ↗
  10. Integrum AB SACQ Acquisition 20,000 shares 16.0K SEK at 0.80 SEK FI filing ↗
  11. Xbrane Biopharma AB SACQ Acquisition 3,612 shares 121.0K SEK at 33.50 SEK FI filing ↗
  12. Xbrane Biopharma AB SACQ Acquisition 6,500 shares 195.0K SEK at 30.00 SEK FI filing ↗
  13. Xbrane Biopharma AB SACQ Acquisition 2,468 shares 74.0K SEK at 30.00 SEK FI filing ↗
  14. Xbrane Biopharma AB SACQ Acquisition 104,000 shares 25.3K SEK at 0.24 SEK FI filing ↗
  15. Xbrane Biopharma AB SACQ Acquisition × 2 5,000 shares 139.7K SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    3,000 5.88 SEK 17.6K SEK FI filing ↗
    2,000 61.04 SEK 122.1K SEK FI filing ↗
  16. Xintela AB SEXI Exercise increasenot a buy/sell decision 20,000 shares 100.0K SEK at 5.00 SEK FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
Integrum AB SE0009807266 Integ B 38,518 $1.04 $40.2K FI marknadssok.fi.se ↗
Xbrane Biopharma AB SE0007789409 aktier 7,000 — — FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where Karin Johansson Wingstrand reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.